CRMD - CorMedix, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue224.105210.13189.274
Cost of Revenue366.673318.718445.799
Gross Profit-142.568-108.588-256.525
Operating Expenses
Research Development15,735.36,281.8231,318.734
Selling General and Administrative8,883.0510,263.567,326.861
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-24,760.918-16,653.971-8,902.12
Income from Continuing Operations
Total Other Income/Expenses Net118.602-1,529.594-11,549.22
Earnings Before Interest and Taxes-24,642.316-18,183.565-20,451.34
Interest Expense1.3113.9642.087
Income Before Tax-24,643.627-18,187.529-20,453.427
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-24,643.627-18,187.529-20,453.427
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-24,643.627-18,187.529-20,453.427
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-24,643.627-18,220.65-20,536.326